Feedback / Questions
ASC30 - Ascletis
https://www.prnewswire.com/news-releases/ascletis-announces-initiation-of-global-phase-iii-for-oral-small-molecule-glp-1-asc30-and-positive-preclinical-data-for-its-first-in-class-oral-small-molecule-glp-1gipamylin-fixed-dose-combination-302841108.html
Aug 3, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next